2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Antineoplastic Agents: new trials by email Literature Review of Antineoplastic Agents trials Research Report on Antineoplastic Agents
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) Idarubicin, Cytarabine, Lenalidomide (Revlimid®) - Myelodysplastic Syndrome, Acute Myeloid Leukemia | Phase 1 / Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 51 | 2009-06-25 | 2020-12-22 |
| To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid Paclitaxel, Drug: Ad.p53-DC vaccines, All -trans Retinoic Acid (ATRA) - Small Cell Lung Cancer | Phase 2 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 69 | 2007-10-02 | 2019-11-08 |
Leukemia, Monocytic, Acute (1) · Leukemia, Myeloid, Acute (1) · Myelodysplastic Syndromes (1) · Small Cell Lung Carcinoma (1)
H. Lee Moffitt Cancer Center and Research Institute (2)
United States (2)
Jeffrey Lancet, M.D. (1) · Scott Antonia, M.D. (1)